Akèy › Anplwayè › CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc.: Salè H-1B ak pajon
CytomX Therapeutics, Inc. depoze 10 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 9. Medyèn salè yo ofri a: $156,347.
Èske CytomX Therapeutics, Inc. pajone visa H-1B?
CytomX Therapeutics, Inc. depoze 10 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Jun 15, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Demands Green Card (PERM) pou CytomX Therapeutics, Inc.: 3 →
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Senior Research Associate | 3 | $107,370 |
| Manager, Clinical Data Management | 2 | $175,590 |
| Scientist II, Oncology | 1 | $127,000 |
| Vice President, Business Development | 1 | $290,000 |
| Senior Manager, Regulatory Affairs and Operations | 1 | $172,489 |
| Associate Scientist, Protein Sciences | 1 | $112,000 |
| Associate Director, Clinical Operations | 1 | $193,170 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 1 | $127,000 |
| FY2024 | 7 | $156,347 |
| FY2026 | 2 | $194,834 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Molecular and Cellular Biologists3
- Data Scientists2
- Biochemists and Biophysicists2
- Marketing Managers1
- Regulatory Affairs Managers1
- Natural Sciences Managers1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Senior Research Associate | $117,916–$140,217 Nivo II | Emeryville, CA | Jun 15, 2026 | Oct 1, 2026 | Retire |
| Manager, Clinical Data Management | $194,834–$215,000 Nivo IV | Emeryville, CA | Jun 12, 2026 | Oct 1, 2026 | Certifye |
| Associate Director, Clinical Operations | $193,170–$221,000 Nivo II | South San Francisco, CA | Sep 20, 2024 | Mar 20, 2025 | Certifye |
| Senior Research Associate | $109,741–$135,000 Nivo II | South San Francisco, CA | Jun 25, 2024 | Dec 20, 2024 | Certifye |
| Senior Manager, Regulatory Affairs and Operations | $172,489–$185,000 | South San Francisco, CA | May 8, 2024 | Aug 23, 2024 | Certifye |
| Manager, Clinical Data Management | $156,347–$190,000 | Belmont, CA | May 1, 2024 | Oct 4, 2024 | Certifye |
| Associate Scientist, Protein Sciences | $112,000–$135,000 Nivo II | South San Francisco, CA | May 1, 2024 | Oct 1, 2024 | Certifye |
| Vice President, Business Development | $290,000–$330,000 Nivo IV | South San Francisco, CA | Mar 21, 2024 | Apr 8, 2024 | Certifye |
| Senior Research Associate | $105,000–$135,000 Nivo II | South San Francisco, CA | Mar 19, 2024 | Sep 7, 2024 | Certifye |
| Scientist II, Oncology | $127,000–$161,000 Nivo III | South San Francisco, CA | Mar 6, 2023 | Aug 3, 2023 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).